Extended HPV genotyping to compare HPV type-distribution in self and provider-collected samples for cervical cancer screening

HPV and Gynecologic Cancer

Predictive value of HPV testing in self-collected and clinician-collected samples compared with cytology in detecting high-grade cervical lesions

Cancer Epidemiol Biomarkers Prev.

El-Zein M, Bouten S, Louvanto K, Gilbert L, Gotlieb WH, Hemmings R, Behr MA, Franco EL

doi: 10.1158/1055-9965.EPI-18-1338

HPV and Gynecologic Cancer

Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions

J Clin Virol.

Leinonen MK, Schee K, Jonassen CM, Lie AK, Nystrand CF, Rangberg A, Furre IE, Johansson MJ, Tropé A, Sjøborg KD, Castle PE, Nygård M

doi: 10.1016/j.jcv.2017.12.008.

HPV and Gynecologic Cancer

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders

Br J Cancer.

Lam JUH, Elfström KM, Ejegod DM, Pedersen H, Rygaard C, Rebolj M, Lynge E, Juul KE, Kjær SK, Dillner J, Bonde J

doi: 10.1038/bjc.2017.371.

HPV and Gynecologic Cancer

Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation

Gynecol Oncol.

Leeman A, Ebisch RMF, Kasius A, Bosgraaf RP, Jenkins D, van de Sandt MM, de Strooper LMA, Heideman DAM, Snijders PJF, Massuger LFAG, Bekkers RLM, Meijer CJLM, van Kemenade FJ, Quint WGV, Melchers WJG

doi: 10.1016/j.ygyno.2018.09.006.

HPV and Gynecologic Cancer

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer

Br J Cancer.

Lagheden C, Eklund C, Lamin H, Kleppe SN, Lei J, Elfström KM, Sundström K, Andrae B, Sparén P, Dillner J

doi: 10.1038/s41416-018-0053-6.

HPV and Gynecologic Cancer

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program

JAMA Intern Med.

Wentzensen N, Clarke MA, Bremer R, Poitras N, Tokugawa D, Goldhoff PE, Castle PE, Schiffman M, Kingery JD, Grewal KK, Locke A, Kinney W, Lorey TS

doi: 10.1001/jamainternmed.

HPV and Gynecologic Cancer

Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France

J Infect.

Lefeuvre C, Pivert A, Guillou-Guillemette HL, Fabiani FL, Veillon P, Banaszuk ALD, Ducancelle A

doi: 10.1016/j.jinf.2020.05.006.

HPV and Gynecologic Cancer

Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial

Lancet Oncol.

Polman NJ, Ebisch RMF, Heideman DAM, Melchers WJG, Bekkers RLM, Molijn AC, Meijer CJLM, Quint WGV, Snijders PJF, Massuger LFAG, van Kemenade FJ, Berkhof J

doi: 10.1016/S1470-

HPV and Gynecologic Cancer

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial

JAMA.

Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ

doi: 10.1001/jama.2018.7464.

Related content

Predictive value of HPV testing in self-collected and clinician-collected samples compared with cytology in detecting high-grade cervical lesions

Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders

Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program

Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France

Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial